Replies to post #84761 on Creative Medical Technology Holdings Inc (CELZ)

[gint1]

CELZ.....I like this Team Better, NO Fakes: Management Team for CaverStem™ ED Treatment
Meet Our CaverStem™Team! Call Us Today for More Information or Simply Request an Appointment Online. We Are Ready to Help You Feel Better!
Timothy Warbington
CEO
Mr. Warbington has over 25 years of executive level management and ownership experience. Mr. Warbington has been a lifescience investor for over 12 years. Since 2011 he has been the CEO of Creative Medical Health, Inc. and Creative Medical Technology Holdings, Inc., a public company and since 2012, CEO of iBiologics, a spin off from the University of Utah. In connection with this experience, he has built a network of scientists, physicians and executives to participate as executive officers and directors of CMH.

Donald Dickerson MBA
CFO
Mr. Dickerson has a Masters of Business Administration, Finance from the University of Southern California. Mr. Dickerson has worked in a number of management and accounting positions and has experience with companies in the technology, manufacturing and health sciences area. Mr. Dickerson’s experience includes leadership positions at BioRasi, Dell, Boeing Capital and Medistem, Inc.

Annette Marleau Phd
Chief Scientific Officer
Prior to joining CMH, Dr. Marleau was the Director of Tumor Immunology at Aethlon Medical Inc. Dr. Marleau has a PhD in Immunology from the University of Western Ontario as well as a MS in Reproductive Immunology from Ontario Veterinary Collateral, University of Guelph, Canada and a BS in Biology from the University of Waterloo, Canada.

Thomas Ichim PhD
President Biotechnology Division
Dr. Ichim has 20 years experience in the biotechnology industry, having served as the Vice President of Cellular Therapies, Intrexon, Inc. Dr. Ichim is an accomplished inventor and was the President and Chief Scientific Officer at Medistem, Inc., a recently acquired publicly traded company. Dr. Ichim has a PhD in Immunology from University of Sciences Arts and Technology, Olveston Monserrat, a MSc in Microbiology and Immunology from University of Western Ontario, London, Ontario, Canada and a BSc in Biology from the University of Waterloo, Waterloo, Ontario, Canada. Dr. Ichim has written over 100 peer reviewed publications and has founded and operated successful biotech companies in the past.